SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. R. Silva, M. Kulldorff, Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance, Biometrics, 2015, 71, 1
  2. 2
    Andrea J. Cook, Robert D. Wellman, Jennifer C. Nelson, Lisa A. Jackson, Ram C. Tiwari, Group sequential method for observational data by using generalized estimating equations: application to Vaccine Safety Datalink, Journal of the Royal Statistical Society: Series C (Applied Statistics), 2015, 64, 2
  3. 3
    Kelly G. Stratton, Andrea J. Cook, Lisa A. Jackson, Jennifer C. Nelson, Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring, Statistics in Medicine, 2015, 34, 7
  4. 4
    Rolina D. Gaalen, Michal Abrahamowicz, David L. Buckeridge, The impact of exposure model misspecification on signal detection in prospective pharmacovigilance, Pharmacoepidemiology and Drug Safety, 2015, 24, 5
  5. 5
    Jeffrey R. Curtis, Susana Perez-Gutthann, Samy Suissa, Pavel Napalkov, Natasha Singh, Liz Thompson, Benjamin Porter-Brown, Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources, Seminars in Arthritis and Rheumatism, 2015, 44, 4, 381

    CrossRef

  6. 6
    Yu-Lin Huang, Jinhee Moon, Jodi B. Segal, A Comparison of Active Adverse Event Surveillance Systems Worldwide, Drug Safety, 2014, 37, 8, 581

    CrossRef

  7. 7
    Judith C. Maro, Jeffrey S. Brown, Gerald J. Dal Pan, Martin Kulldorff, Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity, Pharmacoepidemiology and Drug Safety, 2014, 23, 8
  8. 8
    Elizabeth B. Andrews, Andrea V. Margulis, Patricia Tennis, Suzanne L. West, Opportunities and Challenges in Using Epidemiologic Methods to Monitor Drug Safety in the Era of Large Automated Health Databases, Current Epidemiology Reports, 2014, 1, 4, 194

    CrossRef

  9. 9
    Judith C. Maro, Jeffrey S. Brown, Gerald J. Dal Pan, Lingling Li, Orphan Therapies: Making Best Use of Postmarket Data, Journal of General Internal Medicine, 2014, 29, S3, 745

    CrossRef

  10. 10
    Riley Franks, Sukhminder Sandhu, Armen Avagyan, Yun Lu, Han Hong, Bruno Garcia, Christopher Worrall, Jeffrey Kelman, Robert Ball, Thomas MaCurdy, Robustness properties of a sequential test for vaccine safety in the presence of misspecification, Statistical Analysis and Data Mining: The ASA Data Science Journal, 2014, 7, 5
  11. 11
    J. C. Nelson, O. Yu, C. P. Dominguez-Islas, A. J. Cook, D. Peterson, S. K. Greene, W. K. Yih, M. F. Daley, S. J. Jacobsen, N. P. Klein, E. S. Weintraub, K. R. Broder, L. A. Jackson, Adapting Group Sequential Methods to Observational Postlicensure Vaccine Safety Surveillance: Results of a Pentavalent Combination DTaP-IPV-Hib Vaccine Safety Study, American Journal of Epidemiology, 2013, 177, 2, 131

    CrossRef

  12. 12
    Katharina L. van Santen, Robert A. Bednarczyk, Dzifa Adjaye-Gbewonyo, Walter A. Orenstein, Robert Davis, Saad B. Omer, Effectiveness of Pneumococcal Conjugate Vaccine in Infants by Maternal Influenza Vaccination Status, The Pediatric Infectious Disease Journal, 2013, 32, 11, 1180

    CrossRef

  13. 13
    Judith C. Maro, Jeffrey S. Brown, Martin Kulldorff, Medical Product Safety Surveillance, Epidemiology, 2013, 24, 5, 692

    CrossRef

  14. 14
    José Luis Oliveira, Pedro Lopes, Tiago Nunes, David Campos, Scott Boyer, Ernst Ahlberg, Erik M. Mulligen, Jan A. Kors, Bharat Singh, Laura I. Furlong, Ferran Sanz, Anna Bauer-Mehren, Maria C. Carrascosa, Jordi Mestres, Paul Avillach, Gayo Diallo, Carlos Díaz Acedo, Johan Lei, The EU-ADR Web Platform: delivering advanced pharmacovigilance tools, Pharmacoepidemiology and Drug Safety, 2013, 22, 5
  15. You have free access to this content15
    Andrea J. Cook, Ram C. Tiwari, Robert D. Wellman, Susan R. Heckbert, Lingling Li, Patrick Heagerty, Tracey Marsh, Jennifer C. Nelson, Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot, Pharmacoepidemiology and Drug Safety, 2012, 21,
  16. You have free access to this content16
    Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown, Elizabeth Chrischilles, Lesley H. Curtis, Sean Hennessy, Jennifer C. Nelson, Judith A. Racoosin, Melissa Robb, Sebastian Schneeweiss, Sengwee Toh, Mark G. Weiner, The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction, Pharmacoepidemiology and Drug Safety, 2012, 21,
  17. 17
    Steven J. Jacobsen, Gregory A. Poland, Methods in vaccine effectiveness and safety studies: A critical need for vaccine confidence, Vaccine, 2011, 29, 52, 9573

    CrossRef

  18. 18
    Ryan M. Carnahan, Carlos J. Bell, Richard Platt, Active Surveillance: The United States Food and Drug Administration's Sentinel Initiative,